ATE41307T1 - Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung. - Google Patents

Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung.

Info

Publication number
ATE41307T1
ATE41307T1 AT84108670T AT84108670T ATE41307T1 AT E41307 T1 ATE41307 T1 AT E41307T1 AT 84108670 T AT84108670 T AT 84108670T AT 84108670 T AT84108670 T AT 84108670T AT E41307 T1 ATE41307 T1 AT E41307T1
Authority
AT
Austria
Prior art keywords
aqueous solution
solution containing
soluble active
fat
production
Prior art date
Application number
AT84108670T
Other languages
English (en)
Inventor
Hiroyuki Ohashi
Toru Takami
Noritoshi Koyama
Yoshio Kogure
Katsumi Ida
Kazumi Iijima
Tomohiro Kobori
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE41307T1 publication Critical patent/ATE41307T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT84108670T 1983-07-25 1984-07-23 Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung. ATE41307T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58134260A JPS6025918A (ja) 1983-07-25 1983-07-25 脂溶性薬物含有水性液

Publications (1)

Publication Number Publication Date
ATE41307T1 true ATE41307T1 (de) 1989-04-15

Family

ID=15124133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84108670T ATE41307T1 (de) 1983-07-25 1984-07-23 Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung.

Country Status (11)

Country Link
US (1) US4840970A (de)
EP (1) EP0132821B1 (de)
JP (1) JPS6025918A (de)
KR (1) KR890000700B1 (de)
AT (1) ATE41307T1 (de)
CA (1) CA1218598A (de)
DE (1) DE3477137D1 (de)
ES (1) ES534598A0 (de)
NO (1) NO166835C (de)
PH (1) PH24125A (de)
ZA (1) ZA845541B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573308B1 (fr) * 1984-11-22 1987-01-09 Besins Iscovesco Laboratoires Procede de solubilisation, au moment de l'emploi, d'un principe actif lipophile dans une solution aqueuse, en vue de son administration par voie intraveineuse
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
JPS6217A (ja) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd 安定な活性型ビタミンｄ３類製剤
DE3524788A1 (de) * 1985-07-11 1987-01-22 Lentia Gmbh Stabile, intravenoes applizierbare, waessrige fettemulsion und ein verfahren zu deren herstellung
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
CH667387A5 (it) * 1985-12-24 1988-10-14 Seuref Ag Formulazioni farmaceutiche acquose di ubichinone.
US4711894A (en) * 1986-01-16 1987-12-08 Henkel Corporation Stabilized tocopherol in dry, particulate, free-flowing form
JPH0637379B2 (ja) * 1987-01-19 1994-05-18 サンスタ−株式会社 歯周疾患治療用外用剤
JPS63188624A (ja) * 1987-01-29 1988-08-04 Maruzen Kasei Kk ビタミンｅ含有水性液
US5244925A (en) * 1987-12-18 1993-09-14 Kabi Pharmacia Aktiebolag Emulsion for parenteral administration
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
CA1339029C (en) * 1988-06-20 1997-04-01 Hiroyuki Kakoki Transparent composition
JPH0681739B2 (ja) * 1988-07-11 1994-10-19 エーザイ株式会社 脂溶性ビタミンｋ含有水性液
US5070080A (en) * 1988-08-10 1991-12-03 Fahim Mostafa S Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
US5037655A (en) * 1990-04-18 1991-08-06 Giovanoni Richard L Method of stabilizing tretinoin
ES2051643B1 (es) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
US6616942B1 (en) * 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
DE19944137A1 (de) * 1999-09-15 2001-03-22 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US7060732B2 (en) 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
DE10255195A1 (de) * 2002-11-27 2004-06-09 Lipoid Gmbh Micellare wasserlösliche Konzentrate
EP1670325A1 (de) 2003-09-29 2006-06-21 Soft Gel Technologies, Inc. Solubilisierter coq-10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
JP2006143651A (ja) * 2004-11-19 2006-06-08 Cosmetics Roorando Kk 水溶性化粧品及び食品
DE602006019074D1 (de) * 2005-04-15 2011-02-03 Einstein Coll Med Vitamin k zur vorbeugung und behandlung von hautausschlag infolge einer anti-egfr-therapie
KR100786884B1 (ko) * 2006-06-27 2007-12-20 영진약품공업주식회사 코엔자임 ｑ１０ 함유 수용성 조성물
EP2043685B1 (de) * 2006-07-03 2015-12-23 Genmab A/S Prävention von hautausschlag bei patienten in anti-egfr-therapie
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
KR101066197B1 (ko) 2009-04-06 2011-09-20 한국생명공학연구원 코엔자임 ｑ10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
WO2011153513A2 (en) 2010-06-03 2011-12-08 Latitude Pharma Nanoemulsion composition containing vitamin k

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE700113C (de) * 1939-06-13 1940-12-13 Chemische Ind Ges Verfahren zur Herstellung stabiler sterilisierbarer Emulsionen von gerinnungsaktiventierischen Phosphatiden
US2709149A (en) * 1950-01-26 1955-05-24 Russell P Dunmire Process for producing vitamin compositions
US3143475A (en) * 1961-01-23 1964-08-04 Hoffmann La Roche Vitamin-containing gelatin beadlets and the process of preparing them
US3773930A (en) * 1971-03-23 1973-11-20 Johnson & Johnson Amino acid composition
JPS5356315A (en) * 1976-11-01 1978-05-22 Eisai Co Ltd Emulsified solution of fat soluble drugs
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
JPS59104313A (ja) * 1982-12-06 1984-06-16 Ajinomoto Co Inc 脂溶性ビタミン含有水性液

Also Published As

Publication number Publication date
JPS6025918A (ja) 1985-02-08
CA1218598A (en) 1987-03-03
KR890000700B1 (ko) 1989-03-27
EP0132821A3 (en) 1985-07-10
EP0132821A2 (de) 1985-02-13
NO843002L (no) 1985-01-28
PH24125A (en) 1990-03-05
ES8600931A1 (es) 1985-10-16
JPH0510327B2 (de) 1993-02-09
DE3477137D1 (en) 1989-04-20
NO166835B (no) 1991-06-03
ZA845541B (en) 1985-03-27
NO166835C (no) 1991-09-11
US4840970A (en) 1989-06-20
KR850000972A (ko) 1985-03-14
ES534598A0 (es) 1985-10-16
EP0132821B1 (de) 1989-03-15

Similar Documents

Publication Publication Date Title
ATE41307T1 (de) Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
HUT45023A (en) Process for production of derivatives of 1,5-diphenilpirasole-carbonic acid and selective herbicides containing these compositions as antidotum and derivatives of phenoxipropion acid as herbicide active substance
HU9200857D0 (en) Process for the production of new tiophenecarbonic acid esthers of amino-alcoholes, their quaterner derivatives and of medical preparations containing them as active agents
ATE141166T1 (de) Guanidinaminoglycosid enthaltende liposome
PT83509B (pt) Processo para a preparacao de composicoes farmaceuticas de accao prolongada que contem um sal de metoprolol
DK581185A (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
ES2104605T3 (es) Composiciones estables de acido ascorbico.
HUT45021A (en) Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
DE3678680D1 (de) Alpha-tocopherol(halo)uridin-diester von phosphorsaeure, deren salze und verfahren zu deren herstellung.
JPS57146710A (en) Blood brain-barrier permeating ribosome-like microcapsule
FI894119A0 (fi) Menetelmä isoseriini-N,N-dietikkahapon trinatriumsuolan valmistamiseksi
DE3888307D1 (de) Verfahren zur Herstellung von Ascorbinsäure-2-phosphat.
MY101535A (en) Pharmaceutical compositions
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
HU896587D0 (en) 2-amino-carbonic acid derivatives, and medical preparations containing them as active agents, and process for the production of the active agents and the preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee